Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01024231 |
|---|---|
| Brief Title: | Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma |
| First Submitted : | December 1, 2009 |
| First Submitted that Met QC Criteria : | December 1, 2009 |
| First Posted : | December 2, 2009 (Estimate) |
| Results First Submitted : | August 28, 2020 |
| Results First Submitted that Met QC Criteria : | March 19, 2021 |
| Results First Posted : | March 22, 2021 |
| Last Update Submitted that Met QC Criteria : | March 19, 2021 |
| Last Update Posted : | March 22, 2021 |